Insider transactions Merck KGaA

Stocks

Real-time Estimate Tradegate Other stock markets 10:05:55 2026-07-10 am EDT			5-day change	1st Jan Change
140.25 ^EUR	+0.47%		-3.47%	+14.68%

Jul. 08	Merck Receives FDA Breakthrough Therapy Designation For Enpatoran In Lupus Patients With Active Skin Manifestations	CI
Jul. 08	Merck KGaA's Lupus Drug Gets US FDA Breakthrough Therapy Designation	MT

Date	Insider	Type	Main position	Quantity	Price	Amount	% Market Cap.
Mar. 24	Belén Garijo López	Buy	Chief Executive Officer	3,386	103.53	351K	0.0026%
Mar. 24	Helene von Roeder	Buy	Chief Financial Officer	4,563	103.53	472K	0.0035%
25-03-26	Michaela Freifrau von Glenck	Buy		1,401	130.61	183K	0.0011%
25-03-26	Belén Garijo López	Buy	Chief Executive Officer	2,341	130.61	306K	0.0018%
25-03-26	Matthias Heinzel	Buy	Executive/Senior Manager	4,507	130.61	589K	0.0035%
25-03-26	Peter Guenter	Buy	Executive/Senior Manager	4,507	130.61	589K	0.0035%
24-03-26	Matthias Heinzel	Buy	Executive/Senior Manager	3,884	159.24	619K	0.0030%
24-03-26	Peter Guenter	Buy	Executive/Senior Manager	3,884	159.24	619K	0.0030%
23-03-28	Matthias Heinzel	Buy	Executive/Senior Manager	1,684	172.63	291K	0.0013%
23-03-28	Belén Garijo López	Buy	Chief Executive Officer	636	172.63	110K	0.0005%
22-05-12	Belén Garijo López	Buy	Chief Executive Officer	239,944	159.96	38.38M	0.1857%
21-12-22	Belén Garijo López	Buy	Chief Executive Officer	1,550	220.00	341K	0.0012%
21-09-23	Marcus Kuhnert	Buy	Chief Financial Officer	1,000	199.32	199K	0.0008%